Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

₹ 698 -3.88%
13 Feb - close price
About

Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

Key Points

Business Segment
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 1,530 operational beds, with another 518 beds in the pipeline.

  • Market Cap 8,681 Cr.
  • Current Price 698
  • High / Low 850 / 280
  • Stock P/E 65.1
  • Book Value 28.4
  • Dividend Yield 0.16 %
  • ROCE %
  • ROE 31.2 %
  • Face Value 2.00

Pros

Cons

  • Stock is trading at 24.6 times its book value
  • Debtor days have increased from 52.5 to 65.6 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Dec 2024 Jun 2025 Sep 2025 Dec 2025
114 116 174 190 222
74 86 96 98 121
Operating Profit 40 30 79 92 101
OPM % 35% 26% 45% 48% 45%
3 0 1 1 3
Interest 2 4 2 4 3
Depreciation 6 8 10 10 11
Profit before tax 35 18 69 79 89
Tax % 25% 26% 25% 25% 25%
27 13 51 59 67
EPS in Rs 2.14 1.06 4.12 4.73 5.36
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025
147 205 469
128 159 328
Operating Profit 18 46 141
OPM % 12% 22% 30%
1 3 7
Interest 1 1 11
Depreciation 3 3 29
Profit before tax 15 44 108
Tax % 26% 24% 26%
11 34 80
EPS in Rs 1.23 2.72 6.43
Dividend Payout % 0% 8% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 47%
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 96%
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 176%
1 Year: 95%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 31%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025 Sep 2025
Equity Capital 10 14 25 25
Reserves 26 112 231 329
7 1 117 106
18 24 46 88
Total Liabilities 62 151 419 548
29 60 255 260
CWIP 5 1 11 19
Investments 0 5 4 92
28 86 149 176
Total Assets 62 151 419 548

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025
16 15
-18 -33
-5 48
Net Cash Flow -7 29

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025
Debtor Days 23 39 66
Inventory Days 149 85 78
Days Payable 109 126 64
Cash Conversion Cycle 62 -1 79
Working Capital Days -12 28 31
ROCE % 52%

Shareholding Pattern

Numbers in percentages

Apr 2022Sep 2022Mar 2023Sep 2023Nov 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025
65.89% 65.89% 66.20% 67.91% 67.91% 67.91% 65.84% 63.53% 63.53% 63.61% 63.62%
0.00% 0.00% 0.00% 2.00% 1.79% 0.26% 4.05% 5.95% 5.91% 6.59% 6.31%
0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.07% 0.17% 0.18% 0.15% 0.11%
34.11% 34.11% 33.80% 30.05% 30.30% 31.83% 30.04% 30.34% 30.38% 29.65% 29.97%
No. of Shareholders 1,9518346638151,1072,7213,4235,9676,60316,36222,181

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls